US Stem Cell Inc (USRM)

[Luho]

Btw. RMAT and Cures aren't the same thing. Cures was signed into law in late 2016. RAT (now called RMAT) wasn't unveiled until mid/late January 2017.

I'm assuming you were trying to nit pick my previous post. It wasn't incorrect. The RMAT subset of Cures Act didn't get introduced to the public until January.

But whatever. Whether the wording was misleading or not, it doesn't matter. Point is that January was the key when many people realized there was potential for this penny stock to soar based on RAT being a new option. An option that nobody new would be on the table until late January.

It's crazy that USRM isn't pursuing it any longer. Especially considering how favorable the new head of the FDA is for this area.

I'm glad I'm out majority of my position with profit. But as a healthcare professional, I'm extremely disappointed in this company's decision to no longer pursue something they stated they were publicly pursuing for last few months. It would have been very beneficial to the public and their patients. Even if they don't fully understand how it would work legally at the moment. Comella stated she wanted to bring stem cell therapy to as many patients as possible. This move seems to contradict that statement.